Renin-Angiotensin-Aldosterone System (RAAS) Blockers

Simple item page
dc.contributor.advisorUtidjian, Levon
dc.contributor.authorUtidjian, Levon
dc.contributor.otherChildren's Hospital of Philadelphia
dc.date.accessioned2024-06-10T19:03:14Z
dc.date.available2024-06-10T19:03:14Z
dc.date.created2021-03-01
dc.descriptionThis concept set identifies renin-angiotensin-aldosterone system-blocking medications including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and other agents acting on the renin-angiotensin system. This medication concept set includes the following ingredients: aliskiren, azilsartan, benazepril, candesartan, captopril, cilazapril, enalapril, eprosartan, fosinopril, imidapril, irbesartan, lisinopril, losartan, moexipril, olmesartan, perindopril, quinapril, ramipril, spirapril, telmisartan, trandolapril, valsartan, and zofenopril. It also includes combinations of these ingredients with other antihypertensive medications. This code list was generated by taking the descendants of all the ACE, ARB, and other RAAS agent ingredients of interest, and string matching on the concept_name of the ingredient. It was limited to RxNorm codes. Technical Note: This concept set was created when ingredients were required for some sites. It could be enhanced by using SCDF drug levels and taking descendants, making this easier to refresh.
dc.description.abstractThis broad concept set was intended to identify patients who received angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and other agents acting on the renin-angiotensin system.
dc.identifier.urihttps://pedsnet.org/metadata/handle/20.500.14642/412
dc.language.isoen-US
dc.provenanceTreatment of Henoch-Schonlein purpura (HSP) Nephritis
dc.publisherPEDSnet
dc.relation.isreferencedbyhttps://doi.org/10.1007/s00467-023-06023-8
dc.rightsa CC-BY Attribution 4.0 License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectConcept Set Development::Content Data Model::PEDSnet Data Model
dc.subjectConcept Set Development::Concept Set Evaluation::Clinician Reviewed
dc.subjectConcept Set Development::Concept Set Development Strategy::Broad
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Component
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Component
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Multiple Ingredients
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Precise Ingredient
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Ingredient
dc.subject.meshVasoconstrictor
dc.subject.meshCardiovascular Agent
dc.subject.otherRXNorm
dc.titleRenin-Angiotensin-Aldosterone System (RAAS) Blockers
dspace.entity.typeConceptSet

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
rx_2021_03_ReninAngiotensinAldosteroneSystem_V1.csv
Size:
6.69 MB
Format:
Comma-Separated Values
Download

Domains

Medication Concept Sets

Version History

Now showing 1 - 2 of 2
VersionDateSummary
2
 2024-09-26 09:56:15
Modified to include RXNorm Extension codes.
1*
 2024-06-10 15:03:14
* Selected version